365 related articles for article (PubMed ID: 26033719)
41. Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment.
Kuo CY; Wang WH; Huang CH; Chen YH; Lu PL
J Microbiol Immunol Infect; 2018 Feb; 51(1):88-93. PubMed ID: 28698044
[TBL] [Abstract][Full Text] [Related]
42. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of whole-genome sequence to predict drug resistance of nine anti-
Che Y; Lin Y; Yang T; Chen T; Sang G; Chen Q; He T
Front Public Health; 2022; 10():956171. PubMed ID: 36062095
[TBL] [Abstract][Full Text] [Related]
44. Drug Resistance Characteristics of
Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
[No Abstract] [Full Text] [Related]
45. Antibiotic resistance mechanisms in M. tuberculosis: an update.
Nguyen L
Arch Toxicol; 2016 Jul; 90(7):1585-604. PubMed ID: 27161440
[TBL] [Abstract][Full Text] [Related]
46. Analysis of Mycobacterium tuberculosis isolates from treatment failure patients living in East Timor.
Kelly PM; Lumb R; Pinto A; da Costa G; Sarmento J; Bastian I
Int J Tuberc Lung Dis; 2005 Jan; 9(1):81-6. PubMed ID: 15675555
[TBL] [Abstract][Full Text] [Related]
47. Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates.
Prammananan T; Arjratanakool W; Chaiprasert A; Tingtoy N; Leechawengwong M; Asawapokee N; Leelarasamee A; Dhiraputra C
Int J Tuberc Lung Dis; 2005 Feb; 9(2):216-9. PubMed ID: 15732744
[TBL] [Abstract][Full Text] [Related]
48. The Dual-Targeting Activity of the Metabolite Substrate of Para-amino Salicyclic Acid in the Mycobacterial Folate Pathway: Atomistic and Structural Perspectives.
Agoni C; Ramharack P; Salifu EY; Soliman MES
Protein J; 2020 Apr; 39(2):106-117. PubMed ID: 32086691
[TBL] [Abstract][Full Text] [Related]
49. Mycobacterium resistance to antimycobacterial reagent.
Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L
Therapie; 1999; 54(5):623-5. PubMed ID: 10667100
[TBL] [Abstract][Full Text] [Related]
50. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
Zhao W; Zheng M; Wang B; Mu X; Li P; Fu L; Liu S; Guo Z
Int J Infect Dis; 2016 Nov; 52():23-28. PubMed ID: 27613365
[TBL] [Abstract][Full Text] [Related]
51. Diversified lineages and drug-resistance profiles of clinical isolates of
Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
[TBL] [Abstract][Full Text] [Related]
52. [The resistance of Mycobacterium tuberculosis to PAS].
GIUNIO N
Tuberkuloza; 1954; 6(2-3):135-41. PubMed ID: 13226448
[No Abstract] [Full Text] [Related]
53. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
Şimşek H; Tarhan G; Cesur S
Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
[TBL] [Abstract][Full Text] [Related]
54. Spermine enhances the activity of anti-tuberculosis drugs.
Sao Emani C; Reiling N
Microbiol Spectr; 2024 Jan; 12(1):e0356823. PubMed ID: 38095461
[TBL] [Abstract][Full Text] [Related]
55. [Investigation on Mycobacterium tuberculosis resistance to PAS].
KRSTIC-ARKO K
Tuberkuloza; 1952; 4(1-2):73-83. PubMed ID: 14931571
[No Abstract] [Full Text] [Related]
56. [Effect of PAS on metabolism in Mycobacterium tuberculosis].
WESTFAL I
Med Dosw Mikrobiol; 1952; 4(3):405-6. PubMed ID: 13002061
[No Abstract] [Full Text] [Related]
57. [Effects of antibiotics and chemotherapeutics on mycobacterium tuberculosis typus humanus in incubated chicken eggs; effect of PAS on mycobacterium tuberculosis typus humanus].
KLOSE F; KNOTHE H
Arztl Wochensch; 1952 Jun; 7(26):598-601. PubMed ID: 12976248
[No Abstract] [Full Text] [Related]
58. Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms.
Shi R; Itagaki N; Sugawara I
Mini Rev Med Chem; 2007 Nov; 7(11):1177-85. PubMed ID: 18045221
[TBL] [Abstract][Full Text] [Related]
59. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
Che Y; Bo D; Lin X; Chen T; He T; Lin Y
BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
[TBL] [Abstract][Full Text] [Related]
60. Use of Whole-Genome Sequencing to Predict
Wu X; Tan G; Sha W; Liu H; Yang J; Guo Y; Shen X; Wu Z; Shen H; Yu F
Microbiol Spectr; 2022 Apr; 10(2):e0251621. PubMed ID: 35311541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
